Académique Documents
Professionnel Documents
Culture Documents
patient imprint
PHYSICIAN'S ORDER SHEET
Heart Failure Systolic
Another brand of a generically equivalent product identical in dosage
form and content of active ingredient may be administered unless
indicated.
Allergies: _______________
Admission Status c Fluidrestricted diet not to exceed _____mL per 24 hours
d
e
f
g
g Admit to inpatient to Dr. ______service.
c
d
e
f ******
c Admit to observation to Dr. _________ service.
d
e
f
g c Therapeutic diet_______________.
d
e
f
g
Admit Location IV Fluids
c Admit to location __________________
d
e
f
g c Saline lock
d
e
f
g
Code Status Medications
g Resuscitation status Full Code
c
d
e
f Nitrates
c Resuscitation status Do Not Resuscitate / Do Not
d
e
f
g c nitroglycerin/TRIDIL 5 mcg/min IV titrate up to
d
e
f
g
Intubate (allow natural death) resolution of symptoms, SBP of 100 mm Hg or
maximum dose of 200 mcg/min
c Resuscitation status Partial Code
d
e
f
g
Vital Signs c isosorbide dintrate/ISORDIL 5 milligram orally 3 times
d
e
f
g
a day
g Vitals per unit protocol
c
d
e
f
c isosorbide dintrate/ISORDIL 20 milligram orally 3
d
e
f
g
c Vital signs every_______ hours and then every
d
e
f
g times a day
_____________
c isosorbide mononitrate/ISMO 10 milligram orally 2
d
e
f
g
c Measure and document intake and output Total for
d
e
f
g times a day
every 8 hours
c nitroglycerin/NITROBID 2% topical ointment 1 inch
d
e
f
g
b Measure weight upon admission _____and daily.
c
d
e
f
g applied topically every 6 hours
Evidence
c nitroglycerin/NITROSTAT 0.4 milligram sublingually
d
e
f
g
Activity every 5 minutes as needed for chest pain to a
c Ambulate with Assistance every 8 hours
d
e
f
g maximum of 3 doses. If chest pain not relieved, notify
c Up ad lib
d
e
f
g physician.
c Up to chair
d
e
f
g AngiotensinConverting Enzyme Inhibitors Source
c Bed rest. ____with bathroom privileges; _____and
d
e
f
g An angiotensinconverting enzyme inhibitor or
bedside commode. angiotensin receptor blocker should be prescribed upon
Nursing Orders discharge to patients with an ejection fraction less than
Assessments 40%
Consider calculating Body Mass Index for assessment of c lisinopril /ZESTRIL 5 milligram orally once a day
d
e
f
g
disease severity c lisinopril /ZESTRIL 10 milligram orally once a day
d
e
f
g
Calculator for BMI Source c captopril /CAPOTEN ___mg orally three times a day
d
e
f
g
c Glucose, blood, fingerstick. _______ One Time. Other
d
e
f
g c enalapril/VASOTEC 2.5 milligram mg orally once a
d
e
f
g
Frequency _______________ day
g Measure weight upon admission ____and daily.
c
d
e
f Angiotensin Receptor Blockers Evidence
c Measure I&O and record every shift.
d
e
f
g An angiotensinconverting enzyme inhibitor or
Contingency angiotensin receptor blocker should be prescribed upon
c Notify provider for Temp >101 F, HR >120, HR<60, RR
d
e
f
g discharge to patients with an ejection fraction less than
< 8 or >30, SBP <90 or >180, Urine Output < 120ml 40%
for 4 hrs, Pulse Ox <90% c valsartan/DIOVAN 40 milligram orally once a day
d
e
f
g
Interventions c valsartan/DIOVAN 80 milligram orally once a day
d
e
f
g
c Foley catheter
d
e
f
g Diuretics
c Please notify primary care of admission and status.
d
e
f
g Loop Diuretics Evidence
Respiratory c furosemide /LASIX 40 milligram intravenously 3
d
e
f
g
Oxygen via nasal cannula times a day
c 2 L/min via nc titrate to > 95% by pulse oximetry
d
e
f
g c furosemide /LASIX 40 milligram orally once a day
d
e
f
g
c Pulse oximetry
d
e
f
g c bumetanide /BUMEX 1 milligram intravenously 2
d
e
f
g
Diet times a day
c NPO
d
e
f
g c bumetanide /BUMEX 0.5 milligram orally once a
d
e
f
g
day
Order Initiated By: _________________________ Date/Time: _______________
Physician Signature: ________________________ Date/Time: _______________
Released: April 2, 2009
Telephone/Verbal Orders: gc Read Back g
d
e
f c Confirmed
d
e
f Page &p of &P
patient imprint
PHYSICIAN'S ORDER SHEET
Another brand of a generically equivalent product identical in dosage
form and content of active ingredient may be administered unless
indicated.
Thiazide Diuretics Evidence c atorvastatin /LIPITOR 40 milligram orally once a
d
e
f
g
c metolazone /ZAROXOLYN 5 milligram orally once a
d
e
f
g day, at bedtime
day Give 30 minutes prior to loop dueretics c simvastatin /ZOCOR 20 milligram orally once a day,
d
e
f
g
c metolazone /ZAROXOLYN 2.5 milligram orally once
d
e
f
g in the evening
a day Give 30 minutes prior to loop diuretics c simvastatin /ZOCOR 40 milligram orally once a day,
d
e
f
g
Potassium Supplements in the evening
c potassium chloride If SCr is < or = to 1.8 and GFR >
d
e
f
g Analgesics
or = to 30: if K+ is 3.53.6 give 20 milliequivalents of Opioids Evidence
KCl orally every 4 hours for 3 doses; if K+ is 3.33.4 c morphine 2 milligram intravenously every 4 hours
d
e
f
g
give 40 milliequivalents of KCl every 4 hours for 2 as needed for shortness of breath or wheezing
doses if K+ is less that or equal to 3.2 give 40 meq c morphine 4 milligram intravenously every 4 hours
d
e
f
g
every 4 hours for 3 doses as needed for shortness of breath or wheezing
c potassium chloride IV rider If SCr < or = 1.8 and GFR Antipyretics
d
e
f
g
> /= 30: if K+ is 3.53.6 give 10 meq IV over 1 hour c acetaminophen /TYLENOL ______ orally or rectally
d
e
f
g
times 2; if K+ is 3.33.4 give KCl 10 meq IV over 1 every 4 hours as needed for fever
hours times 3 and if K+ < /+ 3.2 give 10 meq KCl IV c acetaminophen /TYLENOL ______ orally or rectally
d
e
f
g
over 1 hour times 4. every 6 hours as needed for fever
Aldosterone Antagonists Evidence Laxatives
c spironolactone /ALDOSTERONE 25 milligram orally
d
e
f
g c magnesium hydroxide /MILK OF MAGNESIA 30
d
e
f
g
once a day milliliter orally once a day as needed for constipation
BetaBlockers Evidence c docusate sodium /COLACE 100 milligram orally 2
d
e
f
g
A betablocker should be prescribed upon discharge to times a day
patients with an ejection fraction less than or equal to c bisacodyl /DULCOLAX 5 milligram orally once a day as
d
e
f
g
40% needed for constipation
c metoprolol extended release /TOPROL XL 25 milligram
d
e
f
g c bisacodyl /DULCOLAX 10 milligram suppository
d
e
f
g
orally once a day rectally once a day as needed for constipation
c metoprolol extended release /TOPROL XL 50 milligram DVT Prophylaxis
d
e
f
g
orally once a day Mechanical methods of prophylaxis should be used
c carvedilol/COREG 3.125 milligram orally 2 times a
d
e
f
g primarily in patients who are at high risk of bleeding or
day as an adjunct to anticoagulantbased prophylaxis.
c carvedilol/COREG 6.25 milligram orally 2 times a day
d
e
f
g Consider renal impairment when deciding on doses of
Cardiac Glycosides Evidence LMWH, the direct thrombin inhibitors, and other
c digoxin /LANOXIN 0.125 milligram orally once a day
d
e
f
g antithrombotic drugs that are cleared by the kidneys,
Vasodilator Combination Agents Source particularly in elderly patients and those who are at high
c isosorbidehydrALAZINE /BIDIL (37.5/20) 1 tablet
d
e
f
g risk for bleeding.
orally 3 times a day In acutely ill medical patients who have been admitted
Recommended for african american patients per 2006 to the hospital with CHF or severe respiratory disease,
guidlines or who are confined to bed and have one or more
Platelet Inhibitors Evidence adtioanla risk factors, inclujding active CA, previous
Salicylates VTE, sepsis, acute neurologic disease, or inflammatory
For patients with heart failure of nonischemic origin, bowel disease, prophylaxis with LDUH or LMWH is
avoid the routine use of aspirin recommended. In meidcal patients with risk factors for
VTE in whom there is a contraindication to anticoagulant
c aspirin, delayed release 81 milligram orally once a
d
e
f
g
day prophylaxis, GCS or IPC is recommended.
LipidRegulating Agents Evidence c Early and persistant mobilization
d
e
f
g
c ezetimibe/ZETIA 10 MG TAB orally daily
d
e
f
g c Graded compression stockings (1530 mm Hg of
d
e
f
g
HMGCoA Reductase Inhibitors pressure at the ankle)
c atorvastatin /LIPITOR 10 milligram orally once a
d
e
f
g c Sequential Compression Device
d
e
f
g
day, at bedtime c CBC every other day starting on day 4 of heparin
d
e
f
g
c atorvastatin /LIPITOR 20 milligram orally once a
d
e
f
g therapy thru day 14 or until Unfractionated
day, at bedtime heparin/LMWH is discontinued.
Order Initiated By: _________________________ Date/Time: _______________
Physician Signature: ________________________ Date/Time: _______________
Released: April 2, 2009
Telephone/Verbal Orders: gc Read Back g
d
e
f c Confirmed
d
e
f Page &p of &P
patient imprint
PHYSICIAN'S ORDER SHEET
Another brand of a generically equivalent product identical in dosage
form and content of active ingredient may be administered unless
indicated.
LowDose Unfractionated Heparin
c heparin 5,000 unit subcutaneously every 8 hours
d
e
f
g
LowMolecularWeight Heparins
c enoxaparin /LOVENOX 40 milligram subcutaneously
d
e
f
g
once a day
Reminders
Avoid short acting calcium channel blockers Evidence
Laboratory
c Creatine kinase, total (CKtotal) , CKMB isoenzyme, and
d
e
f
g
troponin now if not yet done and every ___ hours Xs 2.
c Complete blood cell count with automated white blood
d
e
f
g
cell differential Evidence
c Basic metabolic panel now if not yet done and repeat
d
e
f
g
________.
c Comprehensive metabolic panel
d
e
f
g
c Lipid panel Evidence
d
e
f
g
c TSH
d
e
f
g
c Btype natriuretic peptide (BNP) Evidence
d
e
f
g
c Btype natriuretic peptide, Nterminal prohormone
d
e
f
g
(proBNP) Evidence
c Magnesium (Mg) Evidence
d
e
f
g
c Ferritin
d
e
f
g
c Digoxin level (therapeutic range 0.5 1 ng/mL per DIG
d
e
f
g
trial) Source
Diagnostic Tests
c 12lead ECG Evidence
d
e
f
g
c Echocardiogram, transthoracic 2D **** Evidence
d
e
f
g
c Radiograph, chest, 1 view Evidence
d
e
f
g
c Radiograph, chest, 2 views Evidence
d
e
f
g
Physician Consults
For patients who are at high risk for clinical deterioration
or hospital admission, a multidisciplinary disease
management program should be used Evidence
c Consult to cardiology
d
e
f
g
c Consult to Palliative Care
d
e
f
g
Other: ______________________________
Order Initiated By: _________________________ Date/Time: _______________
Physician Signature: ________________________ Date/Time: _______________
Released: April 2, 2009
Telephone/Verbal Orders: gc Read Back g
d
e
f c Confirmed
d
e
f Page &p of &P
Print Only Selected Items Print All